Thereafter, by analyzing GSE104580, a HCC cohort of TACE, we found the expression of NAPSB was significantly higher in the TACE response group (Fig. 5D), and the response rates were obviously higher in the NAPSB-high group than in the NAPSB-low group (Fig. 5E). This evidence concerns the gene NAPSB and hepatocellular carcinoma.